ACCD

Accolade, Inc. Common Stock

ACCD

Market cap $576M

Overview Fund Activity

Delisted

ACCD was delisted on the 7th of April, 2025.

Back to rankings

About: Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.

Employees: 2,400

Industrials Specialty Business Services

Financial journalist opinion

TalkingParents Takes Home 11th Accolade For Support Network Initiative

Fort Walton Beach, Aug. 12, 2025 (GLOBE NEWSWIRE) -- The TalkingParents team earned its 11th award since 2022 when it was recognized for meeting the Florida Public Relations Association standard of excellence during the Golden Image Awards held in Orlando, Fla., Aug. 5, 2025. FPRA, the oldest professional association for PR professionals in the U.S., introduced the Golden Image Awards in 1957 to recognize the very best examples of innovation, planning, implementation, and results in public relations.

TalkingParents Takes Home 11th Accolade For Support Network Initiative

The One Show Announces Historic Win: Klick Health Becomes First Health Agency to Ever Receive An Agency of the Year Accolade

NEW YORK & TORONTO--(BUSINESS WIRE)-- #Advertising--Klick Health is capping off The One Club's Creative Week tonight with a groundbreaking win, becoming the first health agency in The One Show's 52-year history to ever be named an Agency of the Year. As The One Show's 2025 Independent Agency of the Year and the recipient of 83 campaign accolades over the course of the week, Klick is helping signal a major advertising industry shift as health creativity increasingly takes center stage. “Klick Health's recognit.

The One Show Announces Historic Win: Klick Health Becomes First Health Agency to Ever Receive An Agency of the Year Accolade

Wellspring Launches Next-Gen Innovation Platform, Accolade Core

Accolade Core and the Core Six Framework Give Innovation Leaders the Tools to Deliver Measurable Business Growth Accolade Core and the Core Six Framework Give Innovation Leaders the Tools to Deliver Measurable Business Growth

Wellspring Launches Next-Gen Innovation Platform, Accolade Core

Pernod completes sale of wine portfolio to Accolade Wines owner

Pernod Ricard has completed the sale of its international wine portfolio, including brands like Jacob's Creek, to Accolade Wines owner Australian Wine Holdco, it said on Wednesday.

Pernod completes sale of wine portfolio to Accolade Wines owner

Digital health startup Transcarent takes Accolade private in $621 million deal

Transcarent on Tuesday announced it has completed its $621 million acquisition of Accolade. Accolade shareholders received $7.03 per share in cash, and the company will no longer be listed on the Nasdaq.

Digital health startup Transcarent takes Accolade private in $621 million deal

Transcarent Completes Merger With Accolade

SAN FRANCISCO & SEATTLE--(BUSINESS WIRE)-- #HealthWayFinding--Today Transcarent announced the successful completion of its merger with Accolade, the leading health advocacy, expert medical opinion, and virtual primary care company in the market. The combined organization now serves over 20 million Members and more than 1,700 employer and health plan clients as the One Place for Health and Care. With the completion of the transaction, Transcarent will offer a health and care experience that is unmatched in its abil.

Transcarent Completes Merger With Accolade

Accolade Stockholders Approve Merger Between Accolade and Transcarent

SEATTLE, March 27, 2025 (GLOBE NEWSWIRE) -- Accolade (NASDAQ:ACCD) announced that Accolade stockholders voted to approve the merger with Transcarent at the Accolade special meeting of stockholders (the “Special Meeting”) held earlier today. The final, certified voting results for the Special Meeting will be provided in a Form 8-K filed with the U.S. Securities and Exchange Commission.

Accolade Stockholders Approve Merger Between Accolade and Transcarent

Accolade Welcomes Oshi Health to Trusted Partner Ecosystem

Partnership increases access to specialized, whole-person clinical care for people managing digestive health conditions SEATTLE , March 6, 2025 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD) has partnered with Oshi Health , a leading virtual clinic specializing in gastrointestinal (GI) conditions that delivers convenient, accessible, whole-person care through a collaborative, multidisciplinary approach. This partnership adds to Accolade's existing GI health partnership with Cylinder and reinforces Accolade's commitment to delivering best-in-class health solutions to customers and their employee and member populations.

Accolade Welcomes Oshi Health to Trusted Partner Ecosystem

Zacks Investment Research

Has Accolade (ACCD) Outpaced Other Business Services Stocks This Year?

Here is how Accolade (ACCD) and Casella (CWST) have performed compared to their sector so far this year.

Has Accolade (ACCD) Outpaced Other Business Services Stocks This Year?

ACCD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Accolade, Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Accolade, Inc. (NASDAQ: ACCD) to Transcarent for $7.03 per share in cash is fair to Accolade shareholders. Halper Sadeh encourages Accolade shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns whether Accolade and its board.

ACCD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Accolade, Inc. Is Fair to Shareholders

See News Rankings

Charts implemented using Lightweight Charts™